IPO
CG Oncology Enters Bladder Cancer Therapy Space With IPO
CG Oncology is a biotech company focused on developing innovative treatments for bladder cancer, particularly non-muscle invasive bladder cancer (NMIB...
DISCOVERIES
Early-Stage Colon Cancer’s Cloak of Invisibility: Unmasking SOX17
Our immune system is complex beyond comprehension. It acts as a vigilant guard, constantly patrolling for and eliminating threats like viruses, bacter...
STARTUPS
Tome Biosciences Defies Biotech Gloom
Earlier this year, a Jefferies analyst quantified the market downturn in the biotechnology sector and came up with a number: 128 companies were tradin...
SCIENCE
The Future of Cancer Treatment: The Three Most Promising Emerging Therapies
Cancer remains one of the world’s leading causes of death. Traditional treatments – surgery, radiation therapy, and chemotherapy – have saved co...